← Back to Search

ACS for Acute Coronary Syndrome (PRISM Trial)

N/A
Recruiting
Research Sponsored by SB Technology, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights
No Placebo-Only Group

Summary

PRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status.

Eligible Conditions
  • Acute Coronary Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Relationship between pre-procedural MCG and the peri-procedural angiography-based measures
Secondary study objectives
Sponsor MCG device safety

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ACSExperimental Treatment1 Intervention
Adult patients who are undergoing a diagnostic angiography or revascularization procedure for the diagnosis or treatment of ischemia or acute coronary syndrome (ACS). Patients are further classified as having low, medium, and high risk for ACS.

Find a Location

Who is running the clinical trial?

Mayo ClinicOTHER
3,326 Previous Clinical Trials
3,059,344 Total Patients Enrolled
7 Trials studying Acute Coronary Syndrome
7,299 Patients Enrolled for Acute Coronary Syndrome
SB Technology, Inc.Lead Sponsor
2 Previous Clinical Trials
140 Total Patients Enrolled
2 Trials studying Acute Coronary Syndrome
140 Patients Enrolled for Acute Coronary Syndrome
Kit Yee Au-Yeung, PhDStudy DirectorSB Technology, Inc.
2 Previous Clinical Trials
140 Total Patients Enrolled
2 Trials studying Acute Coronary Syndrome
140 Patients Enrolled for Acute Coronary Syndrome
~64 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top